In Brief: Cancer Society Endorses Feinstein Bill; Microbead Costs; More
This article was originally published in The Rose Sheet
Executive Summary
Support for the Personal Care Products Safety Act grows, with the American Cancer Society joining a list of advocates that includes public watchdog groups and leading cosmetic companies. More news in brief.
You may also be interested in...
China Coming Around To Animal Test Alternatives, Cruelty Free Says
China revised its cosmetics regulations last year to allow domestic ordinary-use cosmetic manufacturers to substantiate safety without use of animal tests, and in many cases the exemption is being extended to importers, according to Cruelty Free International's Director of Policy Nick Palmer. He says cosmetics that are bottled or packaged in the country are being considered domestics exempt from animal-testing requirements under a "liberal interpretation" of the regulation.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.